• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

What is the Actual Relative Risk of Preeclampsia in Twins Compared to Singletons?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Twins are delivered earlier compared to singletons and therefore overall rates of preeclampsia between twin and singleton pregnancies may underestimate risk of preterm preeclampsia in twins compared to singletons
  • Francisco et al. (Ultrasound in Obstetrics and Gynecology, 2017) sought to determine
    • gestational age at delivery in dichorionic (DC) and monochorionic (MC) twin pregnancies, with and without preeclampsia
    • relative risk of total and preterm preeclampsia compared with that in singleton pregnancies

METHODS:

  • Prospectively collected data to study adverse outcomes in twin pregnancies
  • Patients with twin gestation who had entered care in the first trimester and had aneuploidy screening
  • Inclusion criteria: phenotypically normal live or stillborn babies at ≥ 24 weeks’ gestation
  • Singleton controls from 93,297 singleton pregnancies that were examined in the same hospitals

RESULTS:

  • 1,789 DC and 430 MC twin pregnancies
  • Incidence of preeclampsia was 2.3% in singletons, 8.1% in DC twins, 6.0% in MC twins
  • Compared with singletons, relative risk of total preeclampsia was 3.5 for DC twins and 2.6 for MC twins
  • Incidence of delivery < 37 weeks’ gestation was 5.5% in singletons, 46.5% in DC twins, 91.4% in MC twins
  • Incidence of preterm preeclampsia (< 37 weeks’ gestation) was 0.6% in singletons, 5.5% in DC twins, 5.8% in MC twins
  • Relative risk of preterm preeclampsia was 8.7 for DC twins, 9.1 for MC twins
  • The hazard ratio for DC and MC twin pregnancies relative to singleton pregnancies were 14 and 23, respectively

CONCLUSION:

  • DC and MC twins have similar relative risk for preterm preeclampsia
  • Twins have a significantly higher risk of preterm preeclampsia compared to singletons

Learn More – Primary Sources:

Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy.

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

ASPRE Trial: A Combined Risk Algorithm and Use of Aspirin to Prevent Preterm Preeclampsia
Aspirin Treatment for Women at Risk for Preeclampsia – ACOG and USPSTF Recommendations  
Diagnosing Preeclampsia – Key Definitions and ACOG Guidelines
Do Twins or Singletons Have a Higher Rate of Preterm Mortality?
Does Maternal Age Affect Outcomes in Twins?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site